BONTEFEL
Welcome to the Brand page for “BONTEFEL”, which is offered here for Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, and pain; pharmaceutical preparations, antifungal preparations, dermatological preparations, smoking cessation preparations;.
Its status is currently believed to be active. Its class is unavailable. “BONTEFEL” is believed to be currently owned by “Pfizer Inc.”
| Owner: |
PFIZER INC.
Owner Details |
|---|---|
| Description: |
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, and pain; pharmaceutical preparations, antifungal preparations, dermatological preparations, smoking cessation preparations;
|
| Categories: | PHARMACEUTICAL PREPARATIONS TREATMENT |
